$ATRS ANTARES PHARMA, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ANTARES PHARMA, INC. for free.
IRS Number: 411350192
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: ATRS
Company Address: 100 PRINCETON SOUTH SUITE 300 EWING 08628
Former name: MEDI JECT CORP /MN/, date of change: 1996-06-05
Former name: ANTARES PHARMA INC /MN/, date of change: 2001-06-04
Former name: ANTARES PHARMA INC, date of change: 2002-05-20
Market Capitalization: $356.70M
Prev close: $2.20
Average Daily Volume: 923,232
Days Low: $2.16
Year Low: $0.67
Year High: $2.45
ANTARES PHARMA, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 4.39 | 12,045 | 52,878 | 704,886 | 716.9 K to 704.9 K (-1.68 %) |
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.66 | 40,000 | 66,400 | 0 | |
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.66 | 40,000 | 66,400 | 542,125 | 502.1 K to 542.1 K (+7.97 %) |
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.66 | 40,000 | 66,400 | 0 | |
| May 06 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.66 | 40,000 | 66,400 | 542,125 | 502.1 K to 542.1 K (+7.97 %) |
| May 03 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.66 | 72,669 | 120,631 | 0 | |
| May 03 2021 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.66 | 72,669 | 120,631 | 502,125 | 429.5 K to 502.1 K (+16.92 %) |
| Apr 28 2021 | ATRS | ANTARES PHARMA, IN ... | Richardson Peter C | EVP, R&D Chief Medi ... | Option Exercise | A | 4.01 | 59,179 | 237,308 | 59,179 | |
| Mar 12 2021 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.12 | 50,000 | 56,000 | 0 | |
| Mar 12 2021 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Sell | S | 4.28 | 50,000 | 214,000 | 224,406 | 274.4 K to 224.4 K (-18.22 %) |
| Mar 12 2021 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.12 | 50,000 | 56,000 | 274,406 | 224.4 K to 274.4 K (+22.28 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 4.73 | 35,829 | 169,471 | 691,001 | 726.8 K to 691 K (-4.93 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 0.00 | 80,365 | 0 | 726,830 | 646.5 K to 726.8 K (+12.43 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 0.88 | 250,000 | 220,000 | 0 | |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 5,519 | 14,460 | 0 |